至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease

Neural Regen Res. 2015; 
Teng L, Hong F, Zhang C, He J, Wang H.
Products/Services Used Details Operation
Molecular Biology Tools … The primers were designed using Primer Premier 5 (GenScript Real-time PCR Primer Design, https://www.genscript.com/ssl-bin/app/primer) and DNAStar software (DNAStar company, Madison, WI, USA), and subjected to BLAST analysis (NCBI) … Get A Quote

摘要

Compound Formula Rehmannia has been shown to be clinically effective in treating Parkinson's disease and levodopa-induced dyskinesia; however, the mechanisms remain unclear. In this study, we established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia. Compound Formula Rehmannia inhibited the increase in mRNA expression of N-methyl-D-aspartate receptor subunits 1 and 2 and excitatory amino acid neurotransmitter genes, and it inhibited the reduction in expression of γ-aminobutyric acid receptor B1, an inhibitory amino acid neurotransmitter gene, in the corpus striatum. In addition, Compound Formula Rehmannia alleviated dyskinesia symptoms in the Parki... More

关键词